CERTAIN INFORMATION IN THIS EXHIBIT IDENTIFIED BY [***] IS CONFIDENTIAL AND HAS BEEN EXCLUDED BECAUSE IT (I) IS NOT MATERIAL AND (II) THE REGISTRANT CUSTOMARILY AND ACTUALLY TREATS THAT INFORMATION AS PRIVATE OR CONFIDENTIAL. 22 NOVEMBER 2023Implementation Agreement • November 22nd, 2023 • Freeline Therapeutics Holdings PLC • Biological products, (no disgnostic substances)
EXECUTION VERSION Security Agreement between The Companies listed in Schedule 1 as Chargors and Syncona Portfolio Limited as Lender relating to U.S.$15,000,000 Fixed Rate Convertible Loan Notes due 2024Security Agreement • November 22nd, 2023 • Freeline Therapeutics Holdings PLC • Biological products, (no disgnostic substances)
